Internal Medicine, Nephrology · Miami, FL
NPI
1508849027
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
13500 SW 88th St, Suite 131
Miami, FL, 33186
Phone (305) 388-5222
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,307 services
Medicare patients, 2024
205
Average age 77
Drug cost, 2024
$3.8M
10,431 prescriptions
Company payments, 2025
$634
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco Pons was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 460 times for 159 patients. In total Francisco Pons billed 1,307 services in 23 codes, and Medicare paid $123K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 460 | 159 | $13.68 | $6,291 |
| 99214 Office E&M - Established | Office | 442 | 149 | $103.03 | $46K |
| 90960 ESRD Related Services (not dialysis) | Office | 164 | 27 | $295.25 | $48K |
| 99232 Hospital E&M - Subsequent | Facility | 65 | 23 | $71.41 | $4,642 |
| 99231 Hospital E&M - Subsequent | Facility | 42 | 13 | $45.51 | $1,912 |
| 99204 Office E&M - New | Office | 24 | 24 | $119.34 | $2,864 |
| 90961 ESRD Related Services (not dialysis) | Office | 18 | 11 | $251.16 | $4,521 |
| 99221 Hospital E&M - Initial | Facility | 13 | 13 | $77.34 | $1,005 |
By year: 2022 $170K for 1,352 services; 2023 $154K for 1,198 services; 2024 $123K for 1,307 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francisco Pons prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 1,968 prescriptions and refills. In total Francisco Pons wrote 10,431 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 1,968 | 2,337 | 457 | $1.3M |
| Calcitriol Generic | 1,156 | 2,050 | 328 | $11K |
| Allopurinol Generic | 829 | 1,604 | 242 | $5,300 |
| Jardiance Empagliflozin | 813 | 968 | 200 | $578K |
| Sevelamer Carbonate Generic | 730 | 1,146 | 226 | $77K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 670 | 1,107 | 215 | $2,532 |
| Veltassa Patiromer Calcium Sorbitex | 383 | 398 | 101 | $374K |
| Losartan Potassium Generic | 322 | 685 | 102 | $2,361 |
| Furosemide Generic | 319 | 701 | 95 | $1,038 |
| Olmesartan Medoxomil Generic | 286 | 603 | 86 | $2,244 |
| Hydralazine Hcl Generic | 275 | 478 | 74 | $2,358 |
| Lisinopril Generic | 267 | 542 | 78 | $1,023 |
| Potassium Citrate Er Potassium Citrate | 248 | 445 | 79 | $18K |
| Amlodipine Besylate Generic | 248 | 587 | 90 | $823 |
| Atorvastatin Calcium Generic | 233 | 531 | 83 | $951 |
Brand drugs: 3,698 claims; generic drugs: 6,733 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco Pons $634 ($634 in general payments such as food, travel and fees) from 9 companies. The largest payer was Vifor Pharma, Inc. with $258.
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 18 | $258 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $97.21 |
| OPKO Pharmaceuticals, LLC | 4 | $84.44 |
| Calliditas Therapeutics US Inc. | 2 | $56.52 |
| Ardelyx, Inc. ARDX | 2 | $47.36 |
| Mallinckrodt Hospital Products Inc. | 1 | $30.87 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $25.94 |
| Fresenius USA Marketing, Inc. | 1 | $20.52 |
| Novo Nordisk Inc NVO | 1 | $13.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.